Bioventus Inc. (BVS)
$13.50-0.44%Close
SELLRECOVERY · day 2
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $915M
- Beta
- 0.64
- P/E (TTM)
- 16.80
- Short % float
- 6.77%
- Days to cover
- 6.7
- SI change
- +7.9%
- 1W
- +5.72%
- 1M
- +3.85%
- vs SPY 1W
- +6.70%
- vs SPY 1M
- +1.98%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on BVS?
- LOPJLB’s latest quantitative signal on Bioventus Inc. (BVS) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is BVS in?
- Bioventus Inc. (BVS) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Bioventus Inc. (BVS) do?
- Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The companyâs product portfolio includes pain treatments, which comprise various intra-articular and hyaluronic acid injections; peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthr…